Charles Schwab Investment Management »

Karyopharm Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $75k 13k 5.57

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Schwab Strategic Tr Fundamental Intl (FNDF)
Chevron Corporation (CVX)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Merck & Co (MRK)

View all positions for Charles Schwab Investment Management

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
Adage Capital Partners GP
Susquehanna International
Caption Management
Goldman Sachs Group
Catalio Capital Management
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Millennium Management
Citadel Advisors
Affinity Asset Advisors

View all funds holding Karyopharm Therapeutics